Decrease in reducing power of aqueous humor originating from glaucomatous rabbits

Eye

Volumn 21, Issue 5, 2007, Pages 658-664

  Beit Yannai, E ^a   Trembovler, V ^b   Solomon, A S ^c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; URIC ACID;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; BUPHTHALMOS; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; FEMALE; GLAUCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAOCULAR PRESSURE; MALE; MUTATION; NONHUMAN; OPTOMETRY; OXIDATIVE STRESS; PATHOGENESIS; PRESSURE MEASUREMENT; RABBIT; STUDENT T TEST;

EID: 34248394710     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702353     Document Type: Article

References (41)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-393.
2. Hernandez MR, Pena JD. The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol 1997; 115: 389-395.
3. Egge K, Zahl PH. Survival of glaucoma patients. Acta Ophthalmol Scand 1999; 77: 397-401.
4. Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol 1989; 107: 186-188.
5. Bengtsson B, Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma 2005; 14: 135-138.
6. Green K. Free radicals and aging of anterior segment tissues of the eye: a hypothesis. Ophthalmic Res 1995; 27(Suppl 1): 143-149.
7. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90 7915-7922.
8. Kohen R, Nyska A. Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002; 30: 620-650.
9. Freedman SF, Anderson PJ, Epstein DL. Superoxide dismutase and catalase of calf trabecular meshwork. Invest Ophthalmol Vis Sci 1985; 26 1330-1335.
10. Nguyen KP, Weiss H, Karageuzian LN, Anderson PJ, Epstein DL. Glutathione reductase of calf trabecular meshwork. Invest Ophthalmol Vis Sci 1985; 26: 887-890.
11. Kahn MG, Giblin FJ, Epstein DL. Glutathione in calf trabecular meshwork and its relation to aqueous humor outflow facility. Invest Ophthalmol Vis Sci 1983; 24: 1283-1287.
12. Yan DB, Trope GE, Ethier CR, Menon IA, Wakeham A. Effects of hydrogen peroxide-induced oxidative damage on outflow facility and washout in pig eyes. Invest Ophthalmol Vis Sci 1991; 32: 2515-2520.
13. Flammer J, Haefliger IO, Orgul S, Resink T. Vascular dysregulation: A principal risk factor for glaucomatous damage? J Glaucoma 1999; 8: 212-219.
14. Lipton SA, Lipson SA, Choi YB, Pan ZH, Lei SZ, Chen HS et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626-632.
15. Bautista RD. Glaucomatous neurodegeneration and the concept of neuroprotection. Int Ophthalmol Clin 1999; 39: 57-70.
16. Ratan RR, Baraban JM. Apoptotic death in an in vitro model of neuronal oxidative stress. Clin Exp Pharmacol Physiol 1995; 22 309-310.
17. Choi YB, Lipton SA. Redox modulation of the NMDA receptor. Cell Mol Life Sci 2000; 57: 1535-1541.
18. Mittag T, Schmidt KG. Mechanisms of neuroprotection against glaucoma. Ophthalmologe 2004; 101: 1076-1086.
19. Percicot CL, Schnell CR, Debon C, Hariton C. Continuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: Effects of timolol, dorzolamide, and epinephrine. J Pharmacol Toxicol Methods 1996; 36: 223-228.
20. Ueda J, Sawaguchi S, Hanyu T, Yaoeda. K, Fukuchi T, Abe H et al. Experimental glaucoma model in the rat induced by laser trabecular photocoagulation after an intracameral injection of India ink Jpn J Ophthalmol 1998; 42: 337-344.
21. Gu Z, Yamamoto T, Kaware C, Matsubara B, Kawase K, Sawada A et al. Neuroprotective effect of N-methyl-D-aspartate receptor antagonists in an experimental glaucoma model in the rat. Nippon Ganka Gakkai Zasshi 2000; 104: 11-16.
22. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Beshul CK, Johnson EC et al. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res 1997; 64: 85-96.
23. Luntz MH. Experimental glaucoma in rabbits. Trans Ophthalmol Soc UK 1962; 82: 271-282.
24. Ueno A, Tawara A, Kubota T, Ohnishi Y, Inomata H, Solomon AS et al. Histopathological changes in iridocorneal angle of inherited glaucoma in rabbits. Graefes Arch Clin Exp Ophthalmol 1999; 237: 654-660.
25. Kohen R, Beit-Yannai E, Berry EM, Tirosh O. Overall low molecular weight antioxidant activity of biological fluids and tissues by cyclic voltammetry. Methods Enzymol 1999; 300: 285-296.
26. Kohen R. The use of cyclic voltammetry for the evaluation of oxidative damage in biological samples. J Pharmacol Toxicol Methods 1993; 29: 185-193.
27. Motchnik PA, Frei B, Ames BN. Measurement of antioxidants in human blood plasma. Methods Enzymol 1994; 234: 269-279.
28. Takahashi A, Masuda A, Sun M, Centonze VE, Herman B. Oxidative stress-induced apoptosis is associated with alterations in mitochondrial caspase activity and Bcl-2-dependent alterations in mitochondrial PH (pHm). Brain Res Bull 2004; 62: 497-504.
29. Ko ML, Hu DN, Ritch R, Sharma SC. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest Ophthalmol Vis Sci 2000; 41: 2967-2971.
30. Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 2003; 114: 638-646.
31. Ko ML, Peng PH, Ma MC, Ritch R, Chen CF. Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med 2005; 39: 365-373.
32. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004; 137: 62-69.
33. Geyer O, Wolman Y, Chemihovsky T, Iaina A, Lazar M, Solomon AS. Elevatated NO levels in buphthalmic glaucomatous rabbit eyes. IVOS 1996; 37: S834.
34. Tytell M, Geyer O, Kent CR, Dean DO, Solomon AS. Retinal heat shock protein immunoreactivity in glaucoma. IOVS 1999; 40: S265.
35. Spector A, Garner WH. Hydrogen peroxide and human cataract. Exp Eye Res 1981; 33: 673-681.
36. De La Paz MA, Epstein DL. Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest Ophthalmol Vis Sci 1996; 37: 1849-1853.
37. Lissi E, Salim-Hanna M, Pascual C, del Castillo MD. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 1995; 18: 153-158.
38. Lissi E, Pascual C, del Castillo MD. On the use of the quenching of luminol luminescence to evaluate SOD activity. Free Radic Biol Med 1994; 16: 833-837.
39. Bard AJ, Faulkner LR. Electrochemical Methods: Found Elemental and Applications. John & Wiley & Sons Inc.: New York 1980.
40. Kohen R, Tirosh O, Gorodetsky R. The biological reductive capacity of tissues is decreased following exposure to oxidative stress: A cyclic voltammetry study of irradiated rats. Free Radic Res Commun 1992; 17: 239-248.
41. Shohami E, Gati I, Beit-Yannai E, Trembovler V, Kohen R. Closed head injury in the rat induces whole body oxidative stress: Overall reducing antioxidant profile. J Neurotrauma 1999; 16: 365-376.